BioXcel Therapeutics Inc
NASDAQ:BTAI
BioXcel Therapeutics Inc
NASDAQ:BTAI
Price:
1.63
USD
-2.4%
Market Cap:
$35.6m
Shareholder Yield
Current shareholder yield for 
BTAI is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
Peers Comparison
Shareholder Yield
Shareholder Yield
Price Appreciation
BTAI Price
BioXcel Therapeutics Inc
BioXcel Therapeutics Inc
Annual Price Range
1.63
52w Low
1.18
52w High
6.8
Price Metrics
| Average Annual Return | -57.66% |
| Standard Deviation of Annual Returns | 38.15% |
| Max Drawdown | -100% |
Shares Statistics
| Market Capitalization | 32.6m USD |
| Shares Outstanding | 21 870 000 |
| Percentage of Shares Shorted | 9.09% |
BTAI Return Decomposition
Main factors of price return
Main factors of price return
Stock Splits
BTAI's latest stock split occurred on Feb 10, 2025
The company executed a 1-for-16 stock split, meaning that for every 16 shares held, investors received 1 new share.
Before the split, BTAI traded at 0.165 per share. Afterward, the share price was about 2.98.
The adjusted shares began trading on Feb 10, 2025. This was the only stock split in BTAI's history.
Pre-Split Price
2.64
0.165
Post-Split Price
2.98
Before
After
